Ionis Pharmaceuticals(IONS) - 2023 Q3 - Earnings Call Transcript

Brett Monia Operator Thank you very much for taking my question. With respect to Olezarsen given the recent pivotal data, as you look forward to severe hypertriglyceridemia, how -- I know that you achieved benefits with respect to pancreatitis, you received the reductions. But given the dynamics and differences in that population. How easy do you think it's going to be to show a pancreatitis benefit? My point is that our confidence has grown because the efficacy was so remarkable on reduction in AP events. ...